Venlafaxine Hydrochloride
Product Images NDC 58118-0335

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 58118-0335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 01)

A chart depicting drug interaction effects on venlafaxine pharmacokinetics with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The graph plots PK fold change and 90% confidence intervals for parameters Cmax and AUC, showing recommendations like dose adjustment advice and cautions relative to reference values.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 02)

A chart depicting pharmacokinetic fold changes (Cmax and AUC) for various interacting drugs with venlafaxine hydrochloride. The x-axis shows change relative to a reference value, and drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Recommendations for dose adjustment or caution accompany each drug interaction.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 03)

A scatter plot graph showing fold change and 90% confidence intervals for venlafaxine and ODV pharmacokinetics (Cmax and AUC) across special populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. Recommendations for dose adjustment are noted alongside each population group.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 04)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement, including a methoxy-substituted phenyl ring, a cyclohexanol moiety, and a dimethylaminoethyl side chain.*

FDA Label Image

Venlafaxine Er 75mg

Label for venlafaxine hydrochloride extended-release (ER) 75 mg capsules from Clinical Solutions Wholesale, LLC. The label shows a quantity of 30 capsules, including manufacturing NDC (58118-0335-8), lot number, batch number, and manufacturer details as Zydus Pharmaceuticals (USA), located in Pennington, NJ. The label includes a barcode and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.